Chemical Messenger News and Research

RSS

Protein's new role discovered in autoimmune disease

Investigators at the University of Alabama at Birmingham (UAB) have identified the previously unknown role of a chemical 'messenger' leading to autoimmune disorders like rheumatoid arthritis and lupus.

3 Jan 2008

Profound immune system discovery opens door to halting destruction of lupus

A researcher funded by the Lupus Research Institute (LRI) has discovered an entirely new and powerful molecular switch that controls the inflammatory response of the immune system.

14 Dec 2007

Molecular 'trip switch' shuts down inflammatory response

Like a circuit breaker that prevents electrical wiring from overheating and bringing down the house, a tiny family of three molecules stops the immune system from mounting an out-of-control, destructive inflammatory response against invading pathogens, researchers at the Salk Institute for Biological Studies have found.

14 Dec 2007

Gene-based therapy successful in Parkinson's disease

Brain scans have revealed that the first gene-based therapy for Parkinson's disease was effective.

20 Nov 2007

Inflammation causes insulin resistance not obesity

Researchers at the University of California, San Diego (UCSD) School of Medicine have discovered that inflammation provoked by immune cells called macrophages leads to insulin resistance and Type 2 diabetes.

6 Nov 2007

Why some succumb to stress - new brain mechanism identified

Results of a new study may one day help scientists learn how to enhance a naturally occurring mechanism in the brain that promotes resilience to psychological stress.

19 Oct 2007

Discovery of new area for exploration of schizophrenia

Schizophrenia may occur, in part, because of a problem in an intermittent on/off switch for a gene involved in making a key chemical messenger in the brain, scientists have found in a study of human brain tissue.

17 Oct 2007

Garlic... bad on the nose but good on the heart!

According to the latest research it is the smelly ingredient in garlic that is good for your health.

16 Oct 2007

Schizophrenia candidate genes affect even healthy individuals

Do gene variants that convey risk for schizophrenia affect apparently healthy individuals? Although these genes are present in every human, individuals may have different versions of these genes, called alleles.

1 Oct 2007

Schizophrenia candidate genes affect even healthy individuals

27 Sep 2007

Variations in two genes linked to suicidal thinking

Specific variations in two genes are linked to suicidal thinking that sometimes occurs in people taking the most commonly prescribed class of antidepressants, according to a large study led by scientists at the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH).

27 Sep 2007

New nanoprobe imaging station helps study the distribution of elements in cells

Scientists suspect that iron accumulation plays a role in neurodegenerative processes such as Parkinson's disease, but its distribution in neurons has never been observed because of the lack of techniques to do so. Until today.

26 Sep 2007

Potential new treatment approach for schizophrenia

A new study reports important evidence for a potential new treatment approach for those diagnosed with schizophrenia.

25 Sep 2007

A drug-sensitive 'traffic cop' tells potassium channels to get lost

Our brains are buzzing with electrical activity created by sodium and potassium ions moving in and out of neurons through specialized pores. To prevent the constant chatter from descending into chaos the activity of these ion channels has to be tightly regulated.

3 Sep 2007

Potential new strategies for treating obsessive compulsive disorder

Using genetic engineering, researchers have created an obsessive-compulsive disorder (OCD) - like set of behaviors in mice and reversed them with antidepressants and genetic targeting of a key brain circuit.

24 Aug 2007

Brain areas that control attention thinnest in children with ADHD

Brain areas that control attention were thinnest in children with attention deficit hyperactivity disorder (ADHD) who carried a particular version of a gene in a study by the National Institutes of Health's (NIH) National Institute of Mental Health (NIMH).

7 Aug 2007

Gene variation makes people with depression more likely to respond to the medication citalopram

A variation in a gene called GRIK4 appears to make people with depression more likely to respond to the medication citalopram (Celexa) than are people without the variation, a study by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, has found.

3 Aug 2007

Faster-acting antidepressant medications

A new study has revealed more about how the medication ketamine, when used experimentally for depression, relieves symptoms of the disorder in hours instead of the weeks or months it takes for current antidepressants to work.

25 Jul 2007

Catalyst Pharmaceutical Partners starts U.S. phase II trial of CPP-109 in patients with cocaine dependence

Catalyst Pharmaceutical Partners, Inc. a specialty pharmaceutical company that acquires or in-licenses, develops and commercializes prescription drugs for the treatment of drug addiction, today announced that it has initiated its randomized, double-blind, placebo-controlled U.S. Phase II clinical trial of CPP-109 in patients with cocaine dependence.

11 Jul 2007

Popular antidepressants make elderly bones fragile

Two newly released studies have come out in support for the growing body of evidence that the most popular drugs used to treat depression may contribute to fragile bones in elderly people.

27 Jun 2007